Abstract:Objective: To investigate the relationship between Excision repair cross-complementation 1 (ERCC1) expression, clinicopathological features, and breast cancer prognosis in patients treated with trastuzumab. Further, we aim to explore the immune status of ERCC1 in breast cancer. Methods: The data were retrieved from publicly available databases like the Cancer Genome Atlas, Therapeutically Applicable Research to Generate Effective Treatments, and the Genotype-Tissue Expression. The data was used to perform differential expression analyses between tumor and normal tissues in pan-cancers, immune-related analysis, homologous recombination deficiency (HRD), tumor mutation burden, and microsatellite instability. A total of 210 patients with HER2 over-expressing breast cancer from the Fourth Hospital of Hebei Medical University between January 2013 to December 2015 were enrolled in the study. Ten adjacent normal tissues were used to study the expression pattern of ERCC1 in normal tissues. Immunohistochemistry was performed to study ERCC1 expression and immune cell infiltration in different status of ERCC1 expression. Further, the correlation between ERCC1 expression, immune cell infiltration clinicopathological features, and the prognosis of patients with breast cancer was analyzed. Results: The immune analysis revealed a significant correlation between CD8+ T cell, CD4+ T cell, T helper cell, macrophages, mast cells, and ERCC1 expression. Spearman analysis show that ERCC1 expression is related to macrophages and T cells. A close correlation was observed between increased ERCC1 expression and high tumor immune dysfunction and exclusion (TIDE) score as well as HRD. The results revealed a significant correlation among ERCC1, chemotherapy and estrogen receptor (ER; P < 0.05) expression. Univariate survival analysis revealed a significant correlation (P < 0.05) between that ERCC1 and ER expression, blood vessel invasion, and disease-free survival (DFS). ERCC1 and ER expression, tumor size, blood vessel invasion, pathological type, and lymph node metastases significantly correlated (P < 0.05) with overall survival in patients. Multivariate regression analysis revealed that ERCC1 expression and chemotherapy were independent factors that influence DFS. ERCC1 expression and vascular tumor thrombus were independent influencing factors that influence OS. Conclusion: A correlation was observed between high ERCC1 expression and poor patient prognosis. High ERCC1 expression also influences the efficacy of immunotherapy and chemotherapy.

Expression of extracellular signal-regulated kinase and its relationship with c linicopathological characteristics of breast cancer

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

[Significance of MEK-ERK Cascade in the Development of Human Breast Carcinoma].

The expressing signification of estrogen receptorβ in breast cancer

Increased expression of extracellular signal-regulated kinase in human gastric cancer

Expression of phospho-MAPK in non-small cell cancer and its clinicopathological significance

[Expression and Activation of MAPK Pathway Signaling Molecules in Human Breast Cancer Cell Lines].

Relationship Between ERCC1 Expression and Efficacy of Neoadjuvant Chemotherapy in the Patients with Non-Small-cell Lung Cancer

Increased ERCC1 Protein Expression is Associated with Suboptimal Debulking in Advanced Epithelial Ovarian Cancer.

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

Expression of epidermal growth factor receptor in breast carcinoma before and after chemotherapy and its significance

E Xpression of DNA-PKcs and Its Clinicopathological Significance in Invasive Breast Cancer

Clinical Significance of ERK Phosphorylation in Locally Advanced Colon Carcinoma

ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer

[Expressions of Dab2 and ERK1 in Esophageal Carcinoma Tissues and Their Clinical Significance].

Expression and Significance of ERK and NF-kB in Gastric Adenocarcinoma

Analysis of extracellular regulated protein kinase activation and clinical characteristics in patients with nasal mucosa melanomas

ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling.

The Effect of Extracellular Signal-Regulated Kinases Signaling Pathway Inhibition on Histone Phosphorylation and Gene Expression in Colorectal Canoer Cells

ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma

Expression and its clinical significance of ERCC1 in stage Ⅱ colorectal carcinoma